Novakand Pharma AB (publ) (LARK) — Cash Flow Quality Index
Novakand Pharma AB (publ) (LARK) has a Cash Flow Quality Index of 0.10x as of September 2022. Operating cash flow of Skr379.00K is below net income of Skr3.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Novakand Pharma AB (publ) cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Novakand Pharma AB (publ) Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Novakand Pharma AB (publ) across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LARK total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Novakand Pharma AB (publ) (2021–2021)
Year-by-year earnings quality comparison for Novakand Pharma AB (publ). For live market cap and the full company financial profile, see Novakand Pharma AB (publ) (LARK) market capitalisation.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.05x | Skr22.11 Million | Skr20.96 Million | — |